Business Description
LabTurbo Biotech Corp
ISIN : TW0007725004
Description
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 38.69 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.23 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 10.65 | |||||
Beneish M-Score | -4.04 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -60.8 | |||||
3-Year Book Growth Rate | -8.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.7 | |||||
9-Day RSI | 44.4 | |||||
14-Day RSI | 48.71 | |||||
3-1 Month Momentum % | -4.84 | |||||
6-1 Month Momentum % | -5.83 | |||||
12-1 Month Momentum % | 6.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 18.21 | |||||
Quick Ratio | 16.86 | |||||
Cash Ratio | 16.6 | |||||
Days Inventory | 334.17 | |||||
Days Sales Outstanding | 44.58 | |||||
Days Payable | 28.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.87 | |||||
Forward Dividend Yield % | 0.87 | |||||
5-Year Yield-on-Cost % | 0.87 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 1.32 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -17.74 | |||||
Operating Margin % | -235.15 | |||||
Net Margin % | -166.36 | |||||
EBITDA Margin % | -116.14 | |||||
FCF Margin % | -121.56 | |||||
OCF Margin % | -119.31 | |||||
ROE % | -10.69 | |||||
ROA % | -10.06 | |||||
ROIC % | -40.32 | |||||
3-Year ROIIC % | 998.22 | |||||
ROC (Joel Greenblatt) % | -52.69 | |||||
ROCE % | -10.93 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 13.95 | |||||
PB Ratio | 0.94 | |||||
Price-to-Tangible-Book | 0.98 | |||||
EV-to-EBIT | -2.29 | |||||
EV-to-EBITDA | -3.4 | |||||
EV-to-Revenue | 3.95 | |||||
EV-to-FCF | -3.2 | |||||
| Price-to-Net-Current-Asset-Value | 1.34 | |||||
| Price-to-Net-Cash | 1.49 | |||||
Earnings Yield (Greenblatt) % | -43.76 | |||||
FCF Yield % | -8.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LabTurbo Biotech Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 79.07 | ||
| EPS (TTM) (NT$) | -2.74 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 25.86 | ||
| 14-Day RSI | 48.71 | ||
| 14-Day ATR (NT$) | 0.424867 | ||
| 20-Day SMA (NT$) | 23.315 | ||
| 12-1 Month Momentum % | 6.6 | ||
| 52-Week Range (NT$) | 20.75 - 27.55 | ||
| Shares Outstanding (Mil) | 47.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LabTurbo Biotech Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LabTurbo Biotech Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.200000 Cash Dividend | 2026-07-08 | 24.10 (+0.00%) | ||
| TWD 0.300000 Cash Dividend | 2025-07-02 | 21.00 (+5.26%) |
Show
Entries
LabTurbo Biotech Corp Frequently Asked Questions
What is LabTurbo Biotech Corp(ROCO:7725)'s stock price today?
The current price of ROCO:7725 is NT$23.00. The 52 week high of ROCO:7725 is NT$27.55 and 52 week low is NT$20.75.
When is next earnings date of LabTurbo Biotech Corp(ROCO:7725)?
The next earnings date of LabTurbo Biotech Corp(ROCO:7725) is .
Does LabTurbo Biotech Corp(ROCO:7725) pay dividends? If so, how much?
The Dividend Yield %  of LabTurbo Biotech Corp(ROCO:7725) is 0.87% (As of Today), Highest Dividend Payout Ratio of LabTurbo Biotech Corp(ROCO:7725) was 1.92. The lowest was 1.92. And the median was 1.92. The  Forward Dividend Yield % of LabTurbo Biotech Corp(ROCO:7725) is 0.87%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on LabTurbo Biotech Corp
No articles.